[Pathogenesis and treatment of Behcet's disease].
D000328:Adult; D000818:Animals; D001183:Arthus Reaction / Q000276:immunology; D001285:Atropine / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D003165:Complement System Proteins / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D000882:Haplorhini; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010587:Phagocytosis; D011817:Rabbits; D012173:Retinitis / Q000175:diagnosis; D014605:Uveitis / Q000175:diagnosis
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D001285:Atropine; D003520:Cyclophosphamide; D003165:Complement System Proteins